Clinical Trial Update: Use of HA 330-II for Hemofiltration in Patients With ALF as a Bridge to Liver Transplantation . [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating HA 330-II hemofiltration as a bridge to liver transplantation in patients with acute-on-chronic liver failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• HA 330-II

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: Acute-On-Chronic Liver Failure | Phase 4 | Status: UNKNOWN